Left ventricular lead placement in cardiac resynchronization therapy: Where and how?

Europace

Volumn 11, Issue 5, 2009, Pages 554-561

  Khan, Fakhar Zaman ^a   Virdee, Munmohan Singh ^b   Fynn, Simon Patrick ^b   Dutka, David Paul ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

Cardiac resynchronization therapy; Left ventricular lead position; Myocardial scar

Indexed keywords

LEAD;

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EVALUATION; DISEASE SEVERITY; FUNCTIONAL STATUS; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HOSPITAL ADMISSION; HUMAN; IMPLANTATION; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PATIENT SELECTION; PRIORITY JOURNAL; QRS COMPLEX; REVIEW; SCAR; SURVIVAL;

CICATRIX; DEFIBRILLATORS, IMPLANTABLE; HEART CONDUCTION SYSTEM; HEART FAILURE; HEART VENTRICLES; HUMANS; PACEMAKER, ARTIFICIAL; VENTRICULAR DYSFUNCTION, LEFT;

EID: 66749184826     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup076     Document Type: Review

References (58)

1. St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985-90.
2. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-33.
3. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873- 80.
4. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
5. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA2003;289:2685-94.
6. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
7. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 2006;27:1928-32.
8. Auricchio A, Stellbrink C, Butter C, Sack S, Vogt J, Misier AR et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 2003;42:2109-16.
9. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008;117: 2608-16.
10. Prinzen FW, Augustijn CH, Arts T, Allessie MA, Reneman RS. Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am J Physiol 1990;259:H300-H308.
11. Prinzen FW, Hunter WC, Wyman BT, McVeigh ER. Mapping of regional myocar-dial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol 1999;33:1735-42.
12. Wyman BT, Hunter WC, Prinzen FW, McVeigh ER. Mapping propagation of mechanical activation in the paced heart with MRI tagging. Am J Physiol 1999; 276:H881-H891.
13. Burkhoff D, Oikawa RY, Sagawa K. Influence of pacing site on canine left ventricular contraction. Am J Physiol 1986;251:H428-H435.
14. Park RC, Little WC, O'Rourke RA. Effect of alteration of left ventricular activation sequence on the left ventricular end-systolic pressure-volume relation in closed-chest dogs. Circ Res 1985;57:706-17.
15. Heyndrickx GR, Vantrimpont PJ, Rousseau MF, Pouleur H. Effects of asynchrony on myocardial relaxation at rest and during exercise in conscious dogs. Am J Physiol 1988;254:H817-H822.
16. Ariel Y, Gaasch WH, Bogen DK, McMahon TA. Load-dependent relaxation with late systolic volume steps: servo-pump studies in the intact canine heart. Circulation 1987;75:1287-94.
17. Baller D, Wolpers HG, Zipfel J, Bretschneider HJ, Hellige G. Comparison of the effects of right atrial, right ventricular apex and atrioventricular sequential pacing on myocardial oxygen consumption and cardiac efficiency: a laboratory investigation. Pacing Clin Electrophysiol 1988;11:394- 403.
18. Owen CH, Esposito DJ, Davis JW, Glower DD. The effects of ventricular pacing on left ventricular geometry, function, myocardial oxygen consumption, and efficiency of contraction in conscious dogs. Pacing Clin Electrophysiol 1998;21: 1417-29.
19. Ansalone G, Giannantoni P, Ricci R, Trambaiolo P, Fedele F, Santini M. Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing. J Am Coll Cardiol 2002;39:489-99.
20. Murphy RT, Sigurdsson G, Mulamalla S, Agler D, Popovic ZB, Starling RC et al. Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy. Am J Cardiol 2006;97:1615-21.
21. Becker M, Hoffmann R, Schmitz F, Hundemer A, Kuhl H, Schauerte P et al. Relation of optimal lead positioning as defined by three-dimensional echocardio-graphy to long-term benefit of cardiac resynchronization. Am J Cardiol 2007;100: 1671-6.
22. Becker M, Kramann R, Franke A, Breithardt OA, Heussen N, Knackstedt C et al. Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodeling. A circumferential strain analysis based on 2D echocardio-graphy. Eur Heart J 2007;28:1211-20.
23. Becker M, Franke A, Breithardt OA, Ocklenburg C, Kaminski T, Kramann R et al. Impact of left ventricular lead position on the efficacy of cardiac resynchronisation therapy: a two-dimensional strain echocardiography study. Heart 2007;93: 1197-203.
24. Macias A, Gavira JJ, Alegria E, Azcarate PM, Barba J, Garcia-Bolao I. Effect of the left ventricular pacing site on echocardiographic parameters of ventricular dyssyn-chrony in patients receiving cardiac resynchronization therapy. Rev Esp Cardiol 2004;57:138-45.
25. Helm RH, Byrne M, Helm PA, Daya SK, Osman NF, Tunin R et al. Threedimensional mapping of optimal left ventricular pacing site for cardiac resynchro-nization. Circulation 2007;115:953-61.
26. Dekker AL, Phelps B, Dijkman B, van der Nagel T, van der Veen FH, Geskes GG et al. Epicardial left ventricular lead placement for cardiac resynchronization therapy: optimal pace site selection with pressure-volume loops. J Thorac Cardiovasc Surg 2004;127:1641-7.
27. Ypenburg C, van Bommel RJ, Delgado V, Mollema SA, Bleeker GB, Boersma E et al. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol 2008;52:1402-9.
28. Van de Veire NR, Marsan NA, Schuijf JD, Bleeker GB, Wijffels MC, van Erven L et al. Noninvasive imaging of cardiac venous anatomy with 64-slice multi-slice computed tomography and noninvasive assessment of left ventricular dyssyn-chrony by 3-dimensional tissue synchronization imaging in patients with heart failure scheduled for cardiac resynchronization therapy. Am J Cardiol 2008;101: 1023-9.
29. Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, Cazeau S et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUlti-site STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002;40: 111-8.
30. Molhoek SG, Bax JJ, van Erven L, Bootsma M, Boersma E, Steendijk P et al. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy. Am J Cardiol 2004; 93:860-3.
31. Woo GW, Petersen-Stejskal S, Johnson JW, Conti JB, Aranda JA Jr, Curtis AB. Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study. J Interv Card Electrophysiol 2005;12:107-13.
32. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
33. Adelstein EC, Saba S. Scar burden by myocardial perfusion imaging predicts echo-cardiographic response to cardiac resynchronization therapy in ischemic cardio-myopathy. Am Heart J 2007;153:105-12.
34. Adelstein EC, Saba S. Baseline scintigraphic abnormalities by myocardial perfusion imaging predict echocardiographic response to cardiac resynchronization therapy in nonischemic cardiomyopathy. Clin Cardiol 2008;31:217-24.
35. White JA, Yee R, Yuan X, Krahn A, Skanes A, Parker M et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol 2006;48: 1953-60.
36. Ypenburg C, Roes SD, Bleeker GB, Kaandorp TA, de Roos A, Schalij MJ et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol 2007;99:657-60.
37. Sciagra R, Giaccardi M, Porciani MC, Colella A, Michelucci A, Pieragnoli P et al. Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy. J Nucl Med 2004;45:164-8.
38. Ypenburg C, Schalij MJ, Bleeker GB, Steendijk P, Boersma E, Dibbets-Schneider P et al. Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients. J Nucl Med 2006;47:1565-70.
39. Bleeker GB, Kaandorp TA, Lamb HJ, Boersma E, Steendijk P, de Roos A et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006;113:969-76.
40. Jansen AH, Bracke F, van Dantzig JM, Peels KH, Post JC, van den Bosch HC et al. The influence of myocardial scar and dyssynchrony on reverse remodeling in cardiac resynchronization therapy. Eur J Echocardiogr 2008;9:483-8.
41. Chalil S, Foley PW, Muyhaldeen SA, Patel KC, Yousef ZR, Smith RE et al. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardio-myopathy. Europace 2007;9:1031-7.
42. Chalil S, Stegemann B, Muhyaldeen SA, Khadjooi K, Foley PW, Smith RE et al. Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy. Pacing Clin Electrophysiol 2007;30:1201-9.
43. Riedlbauchova L, Brunken R, Jaber WA, Popova L, Patel D, Lanska V et al. The impact of myocardial viability on the clinical outcome of cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2009;20:50-7.
44. Ypenburg C, Schalij MJ, Bleeker GB, Steendijk P, Boersma E, Dibbets-Schneider P et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J 2007;28:33-41.
45. Arzola-Castaner D, Taub C, Kevin Heist E, Fan D, Haelewyn K, Mela T et al. Left ventricular lead proximity to an akinetic segment and impact on outcome of cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006;17:623-7.
46. tvan Gelder BM, Bracke FA, Meijer A, Lakerveld LJ, Pijls NH. Effect of optimizing the VV interval on left ventricular contractility in cardiac resynchronization therapy. Am J Cardiol 2004;93:1500-3.
47. Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 1999;99:2993-3001.
48. Daoud EG, Kalbfleisch SJ, Hummel JD, Weiss R, Augustini RS, Duff SB et al. Implantation techniques and chronic lead parameters of biventricular pacing dual-chamber defibrillators. J Cardiovasc Electrophysiol 2002;13:964-70.
49. Alonso C, Leclercq C, d'Allonnes FR, Pavin D, Victor F, Mabo P et al. Six year experience of transvenous left ventricular lead implantation for permanent biven-tricular pacing in patients with advanced heart failure: technical aspects. Heart 2001;86:405-10.
50. Gras D, Bocker D, Lunati M, Wellens HJ, Calvert M, Freemantle N et al. Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. Europace 2007;9:516- 22.
51. Leon AR, Abraham WT, Curtis AB, Daubert JP, Fisher WG, Gurley J et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol 2005;46:2348- 56.
52. Alonso C, Leclercq C, Victor F, Mansour H, de Place C, Pavin D et al. Electrocar-diographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure. Am J Cardiol 1999;84:1417-21.
53. Purerfellner H, Nesser HJ, Winter S, Schwierz T, Hornell H, Maertens S. Transvenous left ventricular lead implantation with the EASYTRAK lead system: the European experience. Am J Cardiol 2000;86:157K-164K.
54. Molhoek SG, Bax JJ, van Erven L, Bootsma M, Boersma E, Steendijk P et al. Effectiveness of resynchronization therapy in patients with end-stage heart failure. Am J Cardiol 2002;90:379-83.
55. Koos R, Sinha AM, Markus K, Breithardt OA, Mischke K, Zarse M et al. Comparison of left ventricular lead placement via the coronary venous approach versus lateral thoracotomy in patients receiving cardiac resynchronization therapy. Am J Cardiol 2004;94:59-63.
56. Mair H, Sachweh J, Meuris B, Nollert G, Schmoeckel M, Schuetz A et al. Surgical epicardial left ventricular lead versus coronary sinus lead placement in biventricu-lar pacing. Eur J Cardiothorac Surg 2005;27:235-42.
57. van Gelder BM, Scheffer MG, Meijer A, Bracke FA. Transseptal endocardial left ventricular pacing: an alternative technique for coronary sinus lead placement in cardiac resynchronization therapy. Heart Rhythm 2007;4:454-60.
58. Kassai I, Foldesi C, Szekely A, Szili-Torok T. New method for cardiac resynchro-nization therapy: transapical endocardial lead implantation for left ventricular free wall pacing. Europace 2008;10:882-3.